Published February 6, 2019 | Version v1
Journal article Open

Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder

Authors/Creators

Description

The results leading to this publication have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777394 for the project AIMS-2-TRIALS. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and AUTISM SPEAKS, Autistica, SFARI. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. Any views expressed are those of the author(s) and not necessarily those of the funders.

Files

s41386-019-0333-8.pdf

Files (942.3 kB)

Name Size Download all
md5:fc91a953f8606a9a4a979fb586d19e56
942.3 kB Preview Download

Additional details

Funding

European Commission
AIMS-2-TRIALS - Autism Innovative Medicine Studies – 2 – Trials 777394